After Trial Failure, Tonix Sees Glimmer of Hope for Future of PTSD Drug

글 내용 전체보기

Exact Sciences Shares Rocket as Pfizer Agrees to Co-Market Cologuard Colon Cancer Test

글 내용 전체보기

AbbVie Exercises Option to Develop Argenx Immuno-Oncology Compound

글 내용 전체보기

15 Fastest-Growing Private Life Science Companies in the U.S.

글 내용 전체보기

Take note, I-O players. Bristol-Myers to sell Opdivo in China at half-price: report

글 내용 전체보기

AstraZeneca cans HQ contractor and delays glitzy £500M project—again

글 내용 전체보기

Gleevec antitrust suits against Novartis, after failing initially, fall short again in appeals

글 내용 전체보기

Novartis brings in new CEO to clean up scandal-hit Korean branch: report

글 내용 전체보기

FDA promotion police advance with DTC risk info, disclosure studies

글 내용 전체보기

Endo, building on DTC success, ramps up awareness campaign for Peyronie’s disease

글 내용 전체보기

Allergan’s Esmya rejection deals a blow to women’s health sale prospects

글 내용 전체보기

With just $3M upfront, Sierra buys an unwanted Gilead late-stage cancer drug

글 내용 전체보기

After AdComm rejection, Mallinckrodt’s stannsoporfin gets stiff-armed at FDA

글 내용 전체보기

AbbVie licenses GARP checkpoint inhibitor from Argenx

글 내용 전체보기

Cel-Sci CEO paints ‘promising future’ in letter to shareholders

글 내용 전체보기

WuXi Biologics launches bispecific antibody tech

글 내용 전체보기

Bavarian Nordic: €30m loan to support smallpox vaccine fill/finish plant

글 내용 전체보기

Oxford Genetics: CRISPR patent war casts shadow over use in cell line development

글 내용 전체보기

Experts Reveal Ebola Vaccine Status and Potential

글 내용 전체보기

HTGF invests in biotech start-up adivo

글 내용 전체보기

Why some people with brain markers of Alzheimer’s have no dementia

글 내용 전체보기